PubMed:7641692
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-9 | DNA | denotes | IL-2 gene |
| T2 | 25-35 | protein | denotes | NF-kappa B |
| T3 | 55-59 | protein | denotes | CD28 |
| T4 | 99-113 | protein | denotes | 5-lipoxygenase |
| T5 | 133-154 | protein | denotes | CD28 surface receptor |
| T6 | 251-264 | protein | denotes | interleukin-2 |
| T7 | 266-270 | protein | denotes | IL-2 |
| T8 | 299-320 | cell_type | denotes | primary T lymphocytes |
| T9 | 334-338 | protein | denotes | CD28 |
| T10 | 454-458 | protein | denotes | CD28 |
| T11 | 486-496 | protein | denotes | NF-kappa B |
| T12 | 497-520 | protein | denotes | CD28-responsive complex |
| T13 | 525-529 | protein | denotes | IL-2 |
| T14 | 561-565 | protein | denotes | CD28 |
| T15 | 605-628 | protein | denotes | protein tyrosine kinase |
| T16 | 669-685 | protein | denotes | phospholipase A2 |
| T17 | 690-704 | protein | denotes | 5-lipoxygenase |
| T18 | 728-752 | protein | denotes | lipoxygenase metabolites |
| T19 | 794-798 | protein | denotes | IL-2 |
| T20 | 814-824 | protein | denotes | NF-kappa B |
| T21 | 952-956 | protein | denotes | CD28 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-114 | Sentence | denotes | IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. |
| S2 | 115-295 | Sentence | denotes | Activation of the CD28 surface receptor provides a major costimulatory signal for T cell activation resulting in enhanced production of interleukin-2 (IL-2) and cell proliferation. |
| S3 | 296-541 | Sentence | denotes | In primary T lymphocytes we show that CD28 ligation leads to the rapid intracellular formation of reactive oxygen intermediates (ROIs) which are required for CD28-mediated activation of the NF-kappa B/CD28-responsive complex and IL-2 expression. |
| S4 | 542-705 | Sentence | denotes | Delineation of the CD28 signaling cascade was found to involve protein tyrosine kinase activity, followed by the activation of phospholipase A2 and 5-lipoxygenase. |
| S5 | 706-836 | Sentence | denotes | Our data suggest that lipoxygenase metabolites activate ROI formation which then induce IL-2 expression via NF-kappa B activation. |
| S6 | 837-979 | Sentence | denotes | These findings should be useful for therapeutic strategies and the development of immunosuppressants targeting the CD28 costimulatory pathway. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C13 | 0-20 | NP | denotes | IL-2 gene expression |
| C11 | 25-46 | NP | denotes | NF-kappa B activation |
| C3 | 55-59 | NP | denotes | CD28 |
| C5 | 99-113 | NP | denotes | 5-lipoxygenase |
| C1 | 394-430 | NP | denotes | reactive oxygen intermediates (ROIs) |
| C2 | 431-436 | NP | denotes | which |
| C4 | 454-459 | NP | denotes | CD28- |
| C9 | 525-540 | NP | denotes | IL-2 expression |
| C6 | 690-704 | NP | denotes | 5-lipoxygenase |
| C7 | 762-775 | NP | denotes | ROI formation |
| C8 | 776-781 | NP | denotes | which |
| C10 | 794-809 | NP | denotes | IL-2 expression |
| C12 | 814-835 | NP | denotes | NF-kappa B activation |
| R1 | C2 | C1 | coref-relat | which,reactive oxygen intermediates (ROIs) |
| R2 | C4 | C3 | coref-ident | CD28-,CD28 |
| R3 | C6 | C5 | coref-ident | 5-lipoxygenase,5-lipoxygenase |
| R4 | C8 | C7 | coref-relat | which,ROI formation |
| R5 | C10 | C9 | coref-ident | IL-2 expression,IL-2 expression |
| R6 | C12 | C11 | coref-ident | NF-kappa B activation,NF-kappa B activation |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-9 | DNA_domain_or_region | denotes | IL-2 gene |
| T2 | 25-35 | protein_molecule | denotes | NF-kappa B |
| T3 | 55-59 | protein_molecule | denotes | CD28 |
| T4 | 99-113 | protein_molecule | denotes | 5-lipoxygenase |
| T5 | 133-137 | protein_molecule | denotes | CD28 |
| T6 | 197-214 | other_name | denotes | T cell activation |
| T7 | 251-264 | protein_molecule | denotes | interleukin-2 |
| T8 | 266-270 | protein_molecule | denotes | IL-2 |
| T9 | 276-294 | other_name | denotes | cell proliferation |
| T10 | 299-320 | cell_type | denotes | primary T lymphocytes |
| T11 | 334-338 | protein_molecule | denotes | CD28 |
| T12 | 394-423 | inorganic | denotes | reactive oxygen intermediates |
| T13 | 425-429 | inorganic | denotes | ROIs |
| T14 | 454-458 | protein_molecule | denotes | CD28 |
| T15 | 486-496 | protein_molecule | denotes | NF-kappa B |
| T16 | 497-501 | protein_molecule | denotes | CD28 |
| T17 | 525-529 | protein_molecule | denotes | IL-2 |
| T18 | 561-565 | protein_molecule | denotes | CD28 |
| T19 | 605-628 | protein_family_or_group | denotes | protein tyrosine kinase |
| T20 | 669-685 | protein_molecule | denotes | phospholipase A2 |
| T21 | 690-704 | protein_molecule | denotes | 5-lipoxygenase |
| T22 | 728-740 | protein_molecule | denotes | lipoxygenase |
| T23 | 762-765 | inorganic | denotes | ROI |
| T24 | 794-798 | protein_molecule | denotes | IL-2 |
| T25 | 814-824 | protein_molecule | denotes | NF-kappa B |
| T26 | 873-895 | other_name | denotes | therapeutic strategies |
| T27 | 919-937 | other_name | denotes | immunosuppressants |
| T28 | 952-956 | protein_molecule | denotes | CD28 |